PMID- 21442765 OWN - NLM STAT- MEDLINE DCOM- 20120919 LR - 20211020 IS - 1932-7005 (Electronic) IS - 1932-6254 (Print) IS - 1932-6254 (Linking) VI - 6 IP - 3 DP - 2012 Mar TI - Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells. PG - 214-24 LID - 10.1002/term.419 [doi] AB - Stem cell-based tissue engineering offers immense promise for bone regeneration. The objective of this study was to develop a self-setting, mannitol-containing calcium phosphate cement (CPC) encapsulating human umbilical cord mesenchymal stem cells (hUCMSCs) for bone tissue engineering. hUCMSCs could be an inexhaustible and low-cost alternative to the gold-standard bone marrow MSCs, which require an invasive procedure to harvest. hUCMSCs were encapsulated in alginate beads and mixed into the CPC paste. Water-soluble mannitol porogen was incorporated into CPC to create macropores. The porosity was increased from 49% for the hUCMSC-encapsulating CPC to 64% after adding mannitol and absorbable-fibres (p < 0.05). Flexural strength of the construct was increased from 0.3 MPa to 2.0 MPa via fibres. Live cell percentage was > 80% for all constructs. The ALP and OC gene expressions were low at 1 day and greatly increased at 14 days. The constructs that contained mannitol had significantly higher ALP and OC expressions than that without mannitol. ALP activity of hUCMSCs inside CPC with mannitol and fibre was significantly higher than that without mannitol. At 14 days, mineralization by the encapsulated hUCMSCs was eight-fold higher than that at 1 day. In conclusion, a novel mannitol-containing porous CPC-hUCMSC construct was developed for bone tissue engineering. Its advantages include cell delivery inside a load-bearing CPC that has injectable and in situ setting capabilities. hUCMSCs inside CPC had good viability and successfully osteodifferentiated. The self-setting and strong hUCMSC-encapsulating CPC scaffold is promising for bone tissue engineering in a wide range of orthopaedic and craniofacial applications. CI - Copyright (c) 2011 John Wiley & Sons, Ltd. FAU - Tang, Minghui AU - Tang M AD - Department of Endodontics, Prosthodontics and Operative Dentistry, University of Maryland Dental School, Baltimore, MD 21201, USA. FAU - Weir, Michael D AU - Weir MD FAU - Xu, Hockin H K AU - Xu HH LA - eng GR - R01 DE014190-09/DE/NIDCR NIH HHS/United States GR - R01 DE014190-10/DE/NIDCR NIH HHS/United States GR - R01 DE014190-07A1S1/DE/NIDCR NIH HHS/United States GR - R01 DE014190/DE/NIDCR NIH HHS/United States GR - R01 DE14190/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110327 PL - England TA - J Tissue Eng Regen Med JT - Journal of tissue engineering and regenerative medicine JID - 101308490 RN - 0 (Bone Cements) RN - 0 (Calcium Phosphates) RN - 3OWL53L36A (Mannitol) RN - EC 3.1.3.1 (Alkaline Phosphatase) SB - IM MH - Alkaline Phosphatase/metabolism MH - Bone Cements/*pharmacology MH - Calcification, Physiologic/drug effects MH - Calcium Phosphates/*pharmacology MH - Cell Differentiation/drug effects MH - Cell Survival/drug effects MH - Cells, Immobilized/cytology/drug effects MH - Gene Expression Regulation/drug effects MH - Humans MH - Mannitol/*pharmacology MH - Materials Testing MH - Microscopy, Electron, Scanning MH - Osteogenesis/drug effects MH - Porosity/drug effects MH - Stem Cells/*cytology/*drug effects/enzymology MH - Umbilical Cord/*cytology PMC - PMC3144283 MID - NIHMS287815 EDAT- 2011/03/29 06:00 MHDA- 2012/09/20 06:00 PMCR- 2013/03/01 CRDT- 2011/03/29 06:00 PHST- 2010/09/16 00:00 [received] PHST- 2011/02/17 00:00 [accepted] PHST- 2011/03/29 06:00 [entrez] PHST- 2011/03/29 06:00 [pubmed] PHST- 2012/09/20 06:00 [medline] PHST- 2013/03/01 00:00 [pmc-release] AID - 10.1002/term.419 [doi] PST - ppublish SO - J Tissue Eng Regen Med. 2012 Mar;6(3):214-24. doi: 10.1002/term.419. Epub 2011 Mar 27.